NEW YORK (GenomeWeb News) – PerkinElmer reported after the close of the market on Thursday that its third-quarter revenues declined around 9 percent and its profit tumbled 57 percent

The Waltham, Mass.-based life sciences company reported total revenues of $437.1 million for the three-month period ended Sept. 30, compared to revenues of $478.7 million for the third quarter of 2008. Currency translation had a negative impact of 2 percent for the quarter, while acquisitions had a positive impact of 1 percent.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: method to detect single-nucleotide and copy-number alterations in single cells from archival tissue, and more.

China has announced new rules governing the use of stem cell treatments, Nature News reports.

Wired's Sarah Zhang expresses frustration as a microbiome study of homes uncovers expected bacteria.

A database containing genome sequences from strains of foodborne pathogens may enable regulators and companies to quickly identify outbreak sources, Reuters reports.